Abstract
Brain targeting is a difficult task due to various factors; those factors can restrict the entry of drugs into the brain, in the present study polymer-lipid hybrid nanoparticles were prepared for targeting carbamazepine into the brain through the intranasal route. Five formulations were successfully prepared using chitosan, stearic acid and glyceryl mono stearate in different ratio. The particles size were found between 78.88-790nm, the poly dispersibility index were found in the range of 0.273-0.531, the zeta potential were found to be -7.1, -11.6, 22.3 for HN1, HN2, HN3 respectively and for formulation HN4 and HN5 it was found as +12.1 and +22.3. The entrapment efficiency of all the formulations was found between 62.66-88.31%, the in-vitro releases were found in the range of 40-72%. The in-vivo studies were performed on Wister rats. Formulation HN5 containing higher conc. of chitosan has shown high drug targeting efficiency. The lipid-polymer hybrid nanoparticles have shown the possibility of targeting the brain through intranasal delivery. Keywords : polymer-lipid hybrid Nanoparticles, carbamazepine, brain targeting, chitosan
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
